Hepatocarcinoma

19 registered clinical trials studyying Hepatocarcinoma — 9 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Evaluation of Skin Tests in Biotherapy Allergies NCT06971848	University Hospital, Angers	N/A
Recruiting	Decoding Epigenetic Mechanisms Driving Immune Evasion in Liver Cancer With Omics Approaches NCT07432347	Niguarda Hospital	—
Not Yet Recruiting	Icariin Soft Capsules Combined With TACE as Adjuvant Therapy for HCC NCT06900478	Hua Li	Phase 2
Recruiting	Prediction of Decompensation and HCC Development in Advanced Chronic Liver Disease NCT06523608	University Hospital Muenster	—
Active Not Recruiting	HCC Innervation Assessment NCT06886763	Hospices Civils de Lyon	—
Not Yet Recruiting	Adjuvant Therapy for High-risk Hepatocellular Carcinoma Post Liver Transplantation NCT06041490	Peking Union Medical College Hospital	Phase 2
Recruiting	A Study on the Prevalence of Clinically Useful Mutations in Solid Tumor Characterized by Next Generation Seque NCT06028724	Centro di Riferimento Oncologico - Aviano	—
Recruiting	METabolic PROFILE of Hepatocarcinoma and Pancreatic Tumors NCT05794048	Assistance Publique - Hôpitaux de Paris	N/A
Unknown	HAIC Combined With Anlotinib and TQB2450 as Adjuvant Therapy in HCC Patients With High Risk of Recurrence Afte NCT05311319	Fudan University	Phase 2
Unknown	Efficacy and Safety of Cabozantinib in Patients With Hepatocellular Carcinoma NCT04435977	Istituto Clinico Humanitas	Phase 2
Terminated	Analysis of cfDNA in Patients With Hepatocarcinoma and Treated by Sorafenib or Regorafenib NCT03956940	Institut du Cancer de Montpellier - Val d'Aurelle	N/A
Unknown	Robotic Endomicroscopy to Better Define Resection Strategies Applied to Hepatic Surgery NCT03718078	Mauna Kea Technologies	N/A
Completed	A Dose Escalation Study of LNA-i-Mir-221 for Cancer Treatment NCT04811898	Azienda Ospedaliera Universitaria Mater Domini, Catanzaro	Phase 1
Recruiting	Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid NCT03755739	Second Affiliated Hospital of Guangzhou Medical University	Phase 2 / Phase 3
Recruiting	Huaier Granule for Prevention of Recurrence and Metastasis of Hepatocarcinoma Following Local Ablation NCT03356236	Yue Han	—
Completed	Study on the Quality of Life (QoL) After Liver Surgery NCT05464706	Humanitas Clinical and Research Center	N/A
Completed	Benefit of the Use of 3D Models and Tools in Hepatectomy Planning for Hepatocarcinomas NCT03382327	IHU Strasbourg	N/A
Completed	11C-Choline PET/CT and DWI MRI for Response Assessment of HCC Candidate to TARE NCT02519075	Istituto Clinico Humanitas	—
Completed	Use of DwI-MR to Predict Chemotherapy Response of Liver Metastases and Hepatocarcinoma NCT01411579	Stefano Colagrande	—